Drug Database
Back to search

Italy· 043906039

XADAGO*30 cpr rivestite 50 mg

A safinamide product containing safinamide, registered in Italy by ZAMBON SpA, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC N04BD03

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedXADAGO*30 cpr rivestite 50 mgATCN04BD03REGISTER NO.043906039PACKS LISTED1CHECKEDJune 4, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about safinamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Safinamide is registered in 17 of 19 countries.

Countries holding a registration under ATC N04BD03 (safinamide), each read from that country’s own register.

  • This record: Italy
  • 10 of them publish a price we can compare per daily dose
Search safinamide products by name

Safinamide · ATC N04BD03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of safinamide costs, country by country.

Normalised to the WHO defined daily dose (75 mg), the median price runs from $2.78 in Spain to $5.29 in Italy — a ×1.9 gap.

  • Italy: $5.29 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Safinamide · price per daily dose (75 mg)

USD · FX 28 Sept 2026

  • IT Italy$5.29
  • CH Switzerland$4.79
  • ES Spain$2.78
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Active substance
Safinamide
Manufacturer
ZAMBON SpA
Country
Italy (IT)
ATC code
N04BD03
ATC class
Safinamide
Defined daily dose
75 mg, O
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    043906039
    XADAGO*30 cpr rivestite 50 mg
    EUR 123.82

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

158 interactions on record for safinamide.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check safinamide against other medicinesHow interaction checks work

Safinamide · interactions on record

158 records

  • 18 severe
  • 140 moderate

Most severe, free to view

  • FenfluramineA08AA02severe
  • DexfenfluramineA08AA04severe
  • SibutramineA08AA10severe
  • DoxepinD04AX01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Safinamide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All safinamide products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Belgium · Safinamide Ab, Safinamide Eg
  • Cyprus · Orvago
  • Germany · Safinamid Al, Safinamid Puren
  • Denmark · Safinamid Vivanta
  • Estonia · Safinamide Teva
  • Spain · Safinamida Aurovitas, Safinamida Cinfa
  • Finland · Safinamide Vivanta
  • United Kingdom (Northern Ireland) · Safinamide Amarox, Safinamide Milpharm
  • Greece · Orvago, Safinamide Win Medica
  • Croatia · Safinamid Msn, Safinamide Msn
  • Iceland · Xadago
  • Liechtenstein · Xadago
  • Lithuania · Safinamide Teva
  • Luxembourg · Safinamide Eg
  • Latvia · Safinamide Teva
  • Malta · Safinamide Nio
  • Netherlands · Safinamide Vivanta
  • Norway · Safinamide Vivanta, Xadago
  • Portugal · Safinamida Aurobindo, Safinamida Generis
  • Sweden · Orvago, Safinamid Doc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c60b2634-954c-4e9b-97e5-15d63c31bbe7
GET /v1/drugs/c60b2634-954c-4e9b-97e5-15d63c31bbe7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 123.82,
  "source": "aifa",
  "currency": "EUR",
  "strength": "SAFINAMIDE 50MG 30 UNITA' USO ORALE",
  "substance": "Safinamide",
  "equivalence_group": "GWL",
  "transparency_flag": null
}
API referenceMCP serverPlans

See everything about safinamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console